A Anand

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
    A Anand
    Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
    Arch Gen Psychiatry 57:270-6. 2000
  2. ncbi Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients
    A Anand
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
    Am J Psychiatry 157:1108-14. 2000
  3. ncbi Norepinephrine dysfunction in depression
    A Anand
    Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA
    J Clin Psychiatry 61:16-24. 2000
  4. ncbi Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?
    R M Berman
    Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven 06519, USA
    Arch Gen Psychiatry 56:395-403. 1999
  5. ncbi Limited efficacy of ketoconazole in treatment-refractory major depression
    R T Malison
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Clin Psychopharmacol 19:466-70. 1999
  6. ncbi No effect of light on basal glucagon levels in winter seasonal depressives and comparison subjects
    D A Oren
    Department of Veterans Affairs and Yale University, Mailstop 116A, 950 Campbell Avenue, West Haven, CT 06516, USA
    Psychiatry Res 94:263-6. 2000
  7. ncbi Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
    J H Krystal
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Mol Psychiatry 7:S71-80. 2002

Collaborators

Detail Information

Publications7

  1. ncbi Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
    A Anand
    Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
    Arch Gen Psychiatry 57:270-6. 2000
    ..In this study, we tested the hypothesis that lamotrigine, a drug reported to inhibit glutamate release, will reduce the neuropsychiatric effects of ketamine in humans...
  2. ncbi Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients
    A Anand
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
    Am J Psychiatry 157:1108-14. 2000
    ..In this study, dopamine receptor imaging combined with a pharmacological challenge of amphetamine was used to assess both pre- and postsynaptic aspects of dopamine neurotransmission in euthymic bipolar disorder patients...
  3. ncbi Norepinephrine dysfunction in depression
    A Anand
    Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA
    J Clin Psychiatry 61:16-24. 2000
    ....
  4. ncbi Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?
    R M Berman
    Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven 06519, USA
    Arch Gen Psychiatry 56:395-403. 1999
    ..In our study, medication-free subjects with fully remitted major depression underwent a paradigm of catecholamine depletion, via use of the tyrosine hydroxylase inhibitor alpha-methylparatyrosine...
  5. ncbi Limited efficacy of ketoconazole in treatment-refractory major depression
    R T Malison
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Clin Psychopharmacol 19:466-70. 1999
    ..These findings suggest a limited efficacy for ketoconazole in patients with treatment-refractory major depression...
  6. ncbi No effect of light on basal glucagon levels in winter seasonal depressives and comparison subjects
    D A Oren
    Department of Veterans Affairs and Yale University, Mailstop 116A, 950 Campbell Avenue, West Haven, CT 06516, USA
    Psychiatry Res 94:263-6. 2000
    ..15 comparison subjects before and after at least 1 week of light treatment. No differences were seen between groups or conditions. There was no correlation between glucagon change and antidepressant response...
  7. ncbi Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
    J H Krystal
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Mol Psychiatry 7:S71-80. 2002
    ..Future research will be needed to develop and evaluate new agents with specific glutamate and GABA receptor targets in the treatment of mood disorders...